Selected research
Market Structure
Global Inactivated Probiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Inactivated Probiotics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Inactivated Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Inactivated Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Inactivated Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Inactivated Probiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Inactivated Probiotics include IFF, Huanyi, Scitop, GenMont Biotech, Harbin Qiutianhong Health Technology Group, Probioway, Lesaffre, Lallemand Health Solutions and Glac Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Inactivated Probiotics output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Inactivated Probiotics by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Inactivated Probiotics market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Inactivated Probiotics and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Inactivated Probiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inactivated Probiotics market size, projected growth trends, production technologies, key applications, and end-use industries.
Inactivated Probiotics Segment by Company
IFF
Huanyi
Scitop
GenMont Biotech
Harbin Qiutianhong Health Technology Group
Probioway
Lesaffre
Lallemand Health Solutions
Glac Biotech
Creative Biolabs
Chr. Hansen
Wecare Probiotics
Inactivated Probiotics Segment by Type
Radiation Inactivation
Ultrasound Inactivation
Heat Inactivation
Others
Inactivated Probiotics Segment by Application
Food and Beverages
Medicine and Health Products
Inactivated Probiotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inactivated Probiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inactivated Probiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inactivated Probiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Inactivated Probiotics market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inactivated Probiotics industry.
Chapter 3: Detailed analysis of Inactivated Probiotics market competition landscape. Including Inactivated Probiotics manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Inactivated Probiotics by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Inactivated Probiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Radiation Inactivation
- Ultrasound Inactivation
- Heat Inactivation
- Others
Applications
- Food and Beverages
- Medicine and Health Products
Companies covered
- IFF
- Huanyi
- Scitop
- GenMont Biotech
- Harbin Qiutianhong Health Technology Group
- Probioway
- Lesaffre
- Lallemand Health Solutions
- Glac Biotech
- Creative Biolabs
- Chr. Hansen
- Wecare Probiotics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Inactivated Probiotics Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Inactivated Probiotics Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Inactivated Probiotics Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Inactivated Probiotics Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Inactivated Probiotics Market Dynamics
- 2.1 Inactivated Probiotics Industry Trends
- 2.2 Inactivated Probiotics Industry Drivers
- 2.3 Inactivated Probiotics Industry Opportunities and Challenges
- 2.4 Inactivated Probiotics Industry Restraints
3 Inactivated Probiotics Market by Manufacturers
- 3.1 Global Inactivated Probiotics Production Value by Manufacturers (2021-2026)
- 3.2 Global Inactivated Probiotics Production by Manufacturers (2021-2026)
- 3.3 Global Inactivated Probiotics Average Price by Manufacturers (2021-2026)
- 3.4 Global Inactivated Probiotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Inactivated Probiotics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Inactivated Probiotics Manufacturers, Product Type & Application
- 3.7 Global Inactivated Probiotics Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Inactivated Probiotics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Inactivated Probiotics Players Market Share by Production Value in 2025
- 3.8.3 2025 Inactivated Probiotics Tier 1, Tier 2, and Tier 3
4 Inactivated Probiotics Market by Type
- 4.1 Inactivated Probiotics Type Introduction
- 4.1.1 Radiation Inactivation
- 4.1.2 Ultrasound Inactivation
- 4.1.3 Heat Inactivation
- 4.1.4 Others
- 4.2 Global Inactivated Probiotics Production by Type
- 4.2.1 Global Inactivated Probiotics Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Inactivated Probiotics Production by Type (2021-2032)
- 4.2.3 Global Inactivated Probiotics Production Market Share by Type (2021-2032)
- 4.3 Global Inactivated Probiotics Production Value by Type
- 4.3.1 Global Inactivated Probiotics Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Inactivated Probiotics Production Value by Type (2021-2032)
- 4.3.3 Global Inactivated Probiotics Production Value Market Share by Type (2021-2032)
5 Inactivated Probiotics Market by Application
- 5.1 Inactivated Probiotics Application Introduction
- 5.1.1 Food and Beverages
- 5.1.2 Medicine and Health Products
- 5.2 Global Inactivated Probiotics Production by Application
- 5.2.1 Global Inactivated Probiotics Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Inactivated Probiotics Production by Application (2021-2032)
- 5.2.3 Global Inactivated Probiotics Production Market Share by Application (2021-2032)
- 5.3 Global Inactivated Probiotics Production Value by Application
- 5.3.1 Global Inactivated Probiotics Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Inactivated Probiotics Production Value by Application (2021-2032)
- 5.3.3 Global Inactivated Probiotics Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 IFF
- 6.1.1 IFF Company Information
- 6.1.2 IFF Business Overview
- 6.1.3 IFF Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.1.4 IFF Inactivated Probiotics Product Portfolio
- 6.1.5 IFF Recent Developments
- 6.2 Huanyi
- 6.2.1 Huanyi Company Information
- 6.2.2 Huanyi Business Overview
- 6.2.3 Huanyi Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.2.4 Huanyi Inactivated Probiotics Product Portfolio
- 6.2.5 Huanyi Recent Developments
- 6.3 Scitop
- 6.3.1 Scitop Company Information
- 6.3.2 Scitop Business Overview
- 6.3.3 Scitop Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.3.4 Scitop Inactivated Probiotics Product Portfolio
- 6.3.5 Scitop Recent Developments
- 6.4 GenMont Biotech
- 6.4.1 GenMont Biotech Company Information
- 6.4.2 GenMont Biotech Business Overview
- 6.4.3 GenMont Biotech Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.4.4 GenMont Biotech Inactivated Probiotics Product Portfolio
- 6.4.5 GenMont Biotech Recent Developments
- 6.5 Harbin Qiutianhong Health Technology Group
- 6.5.1 Harbin Qiutianhong Health Technology Group Company Information
- 6.5.2 Harbin Qiutianhong Health Technology Group Business Overview
- 6.5.3 Harbin Qiutianhong Health Technology Group Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.5.4 Harbin Qiutianhong Health Technology Group Inactivated Probiotics Product Portfolio
- 6.5.5 Harbin Qiutianhong Health Technology Group Recent Developments
- 6.6 Probioway
- 6.6.1 Probioway Company Information
- 6.6.2 Probioway Business Overview
- 6.6.3 Probioway Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.6.4 Probioway Inactivated Probiotics Product Portfolio
- 6.6.5 Probioway Recent Developments
- 6.7 Lesaffre
- 6.7.1 Lesaffre Company Information
- 6.7.2 Lesaffre Business Overview
- 6.7.3 Lesaffre Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.7.4 Lesaffre Inactivated Probiotics Product Portfolio
- 6.7.5 Lesaffre Recent Developments
- 6.8 Lallemand Health Solutions
- 6.8.1 Lallemand Health Solutions Company Information
- 6.8.2 Lallemand Health Solutions Business Overview
- 6.8.3 Lallemand Health Solutions Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.8.4 Lallemand Health Solutions Inactivated Probiotics Product Portfolio
- 6.8.5 Lallemand Health Solutions Recent Developments
- 6.9 Glac Biotech
- 6.9.1 Glac Biotech Company Information
- 6.9.2 Glac Biotech Business Overview
- 6.9.3 Glac Biotech Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.9.4 Glac Biotech Inactivated Probiotics Product Portfolio
- 6.9.5 Glac Biotech Recent Developments
- 6.10 Creative Biolabs
- 6.10.1 Creative Biolabs Company Information
- 6.10.2 Creative Biolabs Business Overview
- 6.10.3 Creative Biolabs Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.10.4 Creative Biolabs Inactivated Probiotics Product Portfolio
- 6.10.5 Creative Biolabs Recent Developments
- 6.11 Chr. Hansen
- 6.11.1 Chr. Hansen Company Information
- 6.11.2 Chr. Hansen Business Overview
- 6.11.3 Chr. Hansen Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.11.4 Chr. Hansen Inactivated Probiotics Product Portfolio
- 6.11.5 Chr. Hansen Recent Developments
- 6.12 Wecare Probiotics
- 6.12.1 Wecare Probiotics Company Information
- 6.12.2 Wecare Probiotics Business Overview
- 6.12.3 Wecare Probiotics Inactivated Probiotics Production, Value and Gross Margin (2021-2026)
- 6.12.4 Wecare Probiotics Inactivated Probiotics Product Portfolio
- 6.12.5 Wecare Probiotics Recent Developments
7 Global Inactivated Probiotics Production by Region
- 7.1 Global Inactivated Probiotics Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Inactivated Probiotics Production by Region (2021-2032)
- 7.2.1 Global Inactivated Probiotics Production by Region (2021-2026)
- 7.2.2 Global Inactivated Probiotics Production Forecast by Region (2027-2032)
- 7.3 Global Inactivated Probiotics Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Inactivated Probiotics Production Value by Region (2021-2032)
- 7.4.1 Global Inactivated Probiotics Production Value by Region (2021-2026)
- 7.4.2 Global Inactivated Probiotics Production Value by Region (2027-2032)
- 7.5 Global Inactivated Probiotics Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Inactivated Probiotics Production Value (2021-2032)
- 7.6.2 Europe Inactivated Probiotics Production Value (2021-2032)
- 7.6.3 Asia-Pacific Inactivated Probiotics Production Value (2021-2032)
- 7.6.4 South America Inactivated Probiotics Production Value (2021-2032)
- 7.6.5 Middle East & Africa Inactivated Probiotics Production Value (2021-2032)
8 Global Inactivated Probiotics Consumption by Region
- 8.1 Global Inactivated Probiotics Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Inactivated Probiotics Consumption by Region (2021-2032)
- 8.2.1 Global Inactivated Probiotics Consumption by Region (2021-2026)
- 8.2.2 Global Inactivated Probiotics Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Inactivated Probiotics Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Inactivated Probiotics Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Inactivated Probiotics Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Inactivated Probiotics Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Inactivated Probiotics Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Inactivated Probiotics Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Inactivated Probiotics Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Inactivated Probiotics Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Inactivated Probiotics Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Inactivated Probiotics Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Inactivated Probiotics Value Chain Analysis
- 9.1.1 Inactivated Probiotics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Inactivated Probiotics Production Mode & Process
- 9.2 Inactivated Probiotics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Inactivated Probiotics Distributors
- 9.2.3 Inactivated Probiotics Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst